Eli Lilly and Co (LLY) Stock Price, Chart, News and AI analysis

Q: What is Eli Lilly and Co (LLY)'s P/E Ratio?

The P/E ratio of Eli Lilly and Co is 90.1917

Q: Who is the CEO of Eli Lilly and Co?

Mr. David Ricks is the Chairman of the Board of Eli Lilly and Co, joining the firm since 2012.

Q: What is the price performance of LLY stock?

The current price of LLY is $1,071.99, it has increased 0.05% in the last trading day.

Q: What are the primary business themes or industries for Eli Lilly and Co?

Eli Lilly and Co belongs to Pharmaceuticals industry and the sector is Health Care

Q: What is Eli Lilly and Co market cap?

Eli Lilly and Co's current market cap is $1013.4B

Q: Is Eli Lilly and Co a buy, sell, or hold?

According to wall street analysts, 32 analysts have made analyst ratings for Eli Lilly and Co, including 9 strong buy, 17 buy, 9 hold, 0 sell, and 9 strong sell

Home

Stock

LLY

LLY Price

Eli Lilly and Co

$1,071.44

1.37%

$14.55

At close: Dec 18, 16:00:00 GMT-5

$1,071.99

0.05%

$0.54

Post-market: Dec 18, 20:00:00 GMT-5

360

Report

A+

Final Score

Overview Forecast Earnings Dividends Financials



Features

AI Copilot for Stock & Crypto

Trading Strategies

Megabrain Investors Picks

Resources

Market

Ask AI About LLY

No Data Yet

Supported by

+2.89%

+6.2%

30D

+15.78%

+31.01%

YTD

+37.33%

+2.89%

+6.2%

30D

+15.78%

+31.01%

YTD

+37.33%

Follow-Up Questions

What is Eli Lilly and Co (LLY)'s P/E Ratio?



Who is the CEO of Eli Lilly and Co?



What is the price performance of LLY stock?



What are the primary business themes or industries for Eli Lilly and Co?



What is Eli Lilly and Co market cap?



Is Eli Lilly and Co a buy, sell, or hold?



Eli Lilly and Co (LLY) Price

LLY Stock Price Chart

Related News

Pfizer Chases $48B Obesity Market With $2.1B Licensing Deal

China Halves Alzheimer's Drug Prices, Squeezing Pharma Margins

Eli Lilly Leads Dividend Hikes With 15% Increase

Lilly Partners With MEDI&GENE for Next-Generation Obesity Drug

NanOlogy Taps Former Salarius CEO to Accelerate Cancer Drug Trials

Drug Delivery Market to Hit $450.7B as Biologic Sales Boom

Ulcerative Colitis Market to Expand on New Drug Pipeline

Pharma Giants Lilly, Merck Tipped as Undervalued Buys

Lilly’s 42% Growth Trajectory Overshadows Merck’s Value Proposition

Form Health Targets Employer GLP-1 Costs With New Pricing Model

Lilly CEO to Speak at J.P. Morgan Healthcare Conference

Analyst Cuts Constellation Brands Target On GLP-1 Fears

Gilead Shores Up Oncology Push With Yescarta Data

Abbott Labs Shows Financial Health Amid Sector Volatility

Merck Lifts Dividend, Boosting Shareholder Payout

AbbVie Stock Gains After HSBC Upgrade

Eli Lilly Pipeline Advances Fuel Valuation Debate

Amphastar Generic Approval Challenges Eli Lilly Forteo

Healthcare Stocks Face Policy, Pipeline Headwinds

Biotechs Challenge Lilly's Obesity Drug Dominance

Follow-Up Questions

What is Eli Lilly and Co (LLY)'s P/E Ratio?

Who is the CEO of Eli Lilly and Co?

What is the price performance of LLY stock?

What are the primary business themes or industries for Eli Lilly and Co?

What is Eli Lilly and Co market cap?

Is Eli Lilly and Co a buy, sell, or hold?

Related News

Pfizer Chases $48B Obesity Market With $2.1B Licensing Deal

China Halves Alzheimer's Drug Prices, Squeezing Pharma Margins

Eli Lilly Leads Dividend Hikes With 15% Increase

Lilly Partners With MEDI&GENE for Next-Generation Obesity Drug

NanOlogy Taps Former Salarius CEO to Accelerate Cancer Drug Trials

Drug Delivery Market to Hit $450.7B as Biologic Sales Boom

Ulcerative Colitis Market to Expand on New Drug Pipeline

Pharma Giants Lilly, Merck Tipped as Undervalued Buys

Lilly’s 42% Growth Trajectory Overshadows Merck’s Value Proposition

Form Health Targets Employer GLP-1 Costs With New Pricing Model

Lilly CEO to Speak at J.P. Morgan Healthcare Conference

Analyst Cuts Constellation Brands Target On GLP-1 Fears

Gilead Shores Up Oncology Push With Yescarta Data

Abbott Labs Shows Financial Health Amid Sector Volatility

Merck Lifts Dividend, Boosting Shareholder Payout

AbbVie Stock Gains After HSBC Upgrade

Eli Lilly Pipeline Advances Fuel Valuation Debate

Amphastar Generic Approval Challenges Eli Lilly Forteo

Healthcare Stocks Face Policy, Pipeline Headwinds

Biotechs Challenge Lilly's Obesity Drug Dominance

Follow-Up Questions

What is Eli Lilly and Co (LLY)'s P/E Ratio?

Who is the CEO of Eli Lilly and Co?

What is the price performance of LLY stock?

What are the primary business themes or industries for Eli Lilly and Co?

What is Eli Lilly and Co market cap?

Is Eli Lilly and Co a buy, sell, or hold?